AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2025
Nov 18, 2025
30870_dirs_2025-11-18_9ae52795-0d86-4689-959a-df5b6cb7d36d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-11-18
Reporting Person: Malik Fady Ibraham (EVP Research & Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-18 | Common Stock | M | 2200 | $10.60 | Acquired | 142810 | Direct |
| 2025-11-18 | Common Stock | S | 2200 | $66.45 | Disposed | 140610 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-18 | Incentive Stock Option (Right to Buy) | $10.60 | M | 2200 | Disposed | 2027-02-28 | Common Stock (2200) | Direct |
More from CYTOKINETICS INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18